AB308 is an anti-TIGIT antibody that is FcR-enabled.
SparkCures ID
411
Developed By
Arcus Biosciences, Inc.
Generic Name
AB308
Clinical Trials
No active clinical trials
Resources
There are no resources, links or videos to display for this treatment.
👊 Get Your Favorite On!
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.